JOHNSON KENNETH ERLAND - Insider Non-Derivative Transactions at Xeris Biopharma Holdings, Inc. (XERS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 31, 2024, JOHNSON KENNETH ERLAND's relationship to Xeris Biopharma Holdings, Inc. (XERS) is Officer (See Remarks), and currently has 446,860 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XERS insiders.

Data Source: SEC.
JOHNSON KENNETH ERLAND - Insider Non-Derivative Transactions of XERS Common Stock
JOHNSON KENNETH ERLAND - Insider Non-Derivative Transactions at XERS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 1, 2024 F -- (Common Stock) 15131 2.46 373036
Feb 1, 2024 Acquisition -- (Common Stock) 175000 0 446860
Jan 30, 2024 F -- (Common Stock) 10747 2.66 388167
Jan 4, 2024 F -- (Common Stock) 12400 2.24 398914
Feb 1, 2023 Acquisition -- (Common Stock) 100000 0 269783
Feb 1, 2023 F -- (Common Stock) 3393 1.24 411314
Jan 30, 2023 F -- (Common Stock) 11029 1.26 414707
Jan 4, 2023 F -- (Common Stock) 12400 1.12 425736
Feb 1, 2022 F -- (Common Stock) 2307 2.11 438136
Jan 30, 2022 F -- (Common Stock) 7497 2.11 440443